Rituximab for immune hemolytic anemia following T- and b-cell-depleted hematopoietic stem cell transplantation

Acta Haematologica

Volumn 109, Issue 1, 2003, Pages 43-45

  Corti, P ^a   Bonanomi, S ^a   Vallinoto, C ^a   Balduzzi, A ^a   Uderzo, C ^a   Cazzaniga, G ^b   Gaipa, G ^a   Dassi, M ^b   Perseghin, P ^b   Rovelli, Attilio ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b SAN GERARDO HOSPITAL   (Italy)

Author keywords

Hematopoietic stem cell transplantation; Hurler syndrome; Immune hemolytic anemia; Storage diseases

Indexed keywords

RITUXIMAB; CD19 ANTIGEN; HEMOGLOBIN; MONOCLONAL ANTIBODY;

ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; B LYMPHOCYTE; BLOOD DONOR; CASE REPORT; CHILD; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LABORATORY TEST; PRIORITY JOURNAL; T LYMPHOCYTE; ALLOTRANSPLANTATION; BLOOD; CYTOLOGY; HISTOCOMPATIBILITY; HURLER SYNDROME; INFANT; LYMPHOCYTE DEPLETION; METABOLISM; TREATMENT OUTCOME;

ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANTIBODIES, MONOCLONAL; ANTIGENS, CD19; B-LYMPHOCYTES; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOGLOBINS; HUMANS; INFANT; LYMPHOCYTE DEPLETION; MUCOPOLYSACCHARIDOSIS I; T-LYMPHOCYTES; TRANSPLANTATION CHIMERA; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 19044400950     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000067271     Document Type: Article

References (12)

1. Drobysky WR, Potluri J, Sauer D, Gottschall JL: Autoimmune hemolytic anemia following T cell-depleted allogeneic bone marrow transplantation. Bone Marrow Transplant 1996;17: 1093-1099.
2. Chen FE, Owen I, Savage D, Roberts I, Apperley J, Goldman JM, Laffan M: Late onset haemolysis and red cell autoimmunisation after allogeneic bone marrow transplant. Bone Marrow Transplant 1997;19:491-495.
3. Cwynarski K, Goulding R, Pocock C, Dazzi F, Craddock C, Kaeda J, Olavarria E, Kanfer E, Apperley J, Lawler M, Goldman JM: Immune haemolytic anaemia following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukaemia: Association with leukaemic relapse and treatment with donor lymphocyte infusions. Bone Marrow Transplant 2001;28:581-586.
4. Coiffier B, Haioun C, Ketterer N, Egert A, Tilly H, Ma D, Johnson P, Lister A, Feuring-Buske M, Radford JA, Capdeville R, Diehl V, Reyes F: Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: A multicenter phase II study. Blood 1998;92:1927-1932.
5. McGuirk JP, Seropian S, Howe G, Smith B, Stoddart L, Cooper DL: Use of rituximab and irradiated donor-derived lymphocytes to control Epstein-Barr virus associated lymphoproliferation in patients undergoing related haploidentical stem cell transplantation. Bone Marrow Transplant 1999;24:1253-1258.
6. Berenstein S, Tjonnfjord GE, Brudevold R, Gjertsen BT, Langholm R, Lokkevik E, Sorbo JH, Ulvestad E: Favourable response to therapy with the anti-CD20 monoclonal antibody rituximab in primary chronic cold agglutinin disease. Br J Haematol 2001;115:79-83.
7. Zaja F, Russo D, Fuga G, Perella G, Baccarani M: Rituximab for myasthenia gravis developing after bone marrow transplant. Neurology 2000;55:1062-1063.
8. Stasi R, Pagano A, Stipa E, Amadori S: Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura. Blood 2001;98: 952-957.
9. Zecca M, De Stefano P, Nobili B, Locatelli F: Anti-CD20 monoclonal antibody for the treatment of severe immuno-mediated, pure red cell aplasia and hemolytic anemia. Blood 2001;97: 3995-3997.
10. Zaja F, Iacona I, Masolini P, Russo D, Sperotto A, Prosdocimo S, Patriarca F, De Vita S, Regazzi M, Baccarani M, Fanin R: B-cell depletion with rituximab as treatment for immune haemolytic anemia and chronic thrombocytopenia. Haematologica 2002;87:189-195.
11. Seeliger S, Baumann M, Mohr M, Jurgens H, Frosch M, Vormoor J: Autologous peripheral blood stem cell transplantation and anti-B-cell directed immunotherapy for refractory autoimmune haemolytic anaemia. Eur J Pediatr 2001;160:492-496.
12. Quartier P, Brethon B, Philippet P, Landman-Parker J, Le Deist F, Fischer A: Treatment of childhood autoimmune haemolytic anaemia with rituximab. Lancet 2001;358:1511-1513.